Literature DB >> 9200002

Plasmin-mediated proteolysis of osteocalcin.

J F Novak1, J D Hayes, S K Nishimoto.   

Abstract

Plasmin cleaves osteocalcin at a site within its carboxyl end, thus creating an N-midterminal 1-43 and a short C-terminal 44-49 peptides. The products of the cleavage were identified by matrix assisted laser desorption ionization time of flight mass spectrophotometry and by reversed phase high performance liquid chromatography followed by N-terminal sequence determination. When separated by sodium dodecyl sulfide-polyacrylamide gel electrophoresis in the presence of reducing agents, large (LF; N-midterminal) and a small molecular weight (SF; C-terminal) fragments can be identified. The major cleavage site involves arg43-arg44 amino acid residues, and the resulting 44-49 C-terminal fragment appears as a slow migrating band on native gels (SFnat). Elevated levels of calcium ion inhibit the plasmin-mediated lysis of osteocalcin. Plasmin-mediated cleavage of osteocalcin occurs both in solution and when bound to hydroxyapatite. Both osteocalcin cleavage products detach from the hydroxyapatite substrate. Diisopropyl fluorophosphate-inhibited plasmin does not displace osteocalcin from the hydroxyapatite surface. Previously, the C-terminal pentapeptide has been shown to be chemotactic for bone cells while bone particles lacking osteocalcin were resistant to bone resorption. We therefore hypothesize that the plasmin-mediated digestion of free and hydroxyapatite-bound osteocalcin could play a role in the regulation of bone remodeling.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200002     DOI: 10.1359/jbmr.1997.12.7.1035

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  8 in total

1.  Plasmin is essential in preventing periodontitis in mice.

Authors:  Rima Sulniute; Tomas Lindh; Malgorzata Wilczynska; Jinan Li; Tor Ny
Journal:  Am J Pathol       Date:  2011-06-02       Impact factor: 4.307

2.  Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization.

Authors:  S M Nordstrom; S M Carleton; W L Carson; M Eren; C L Phillips; D E Vaughan
Journal:  Bone       Date:  2007-08-17       Impact factor: 4.398

3.  Extracellular proteolysis of reelin by tissue plasminogen activator following synaptic potentiation.

Authors:  J H Trotter; A L Lussier; K E Psilos; H L Mahoney; A E Sponaugle; H-S Hoe; G W Rebeck; E J Weeber
Journal:  Neuroscience       Date:  2014-06-02       Impact factor: 3.590

4.  The three-dimensional structure of bovine calcium ion-bound osteocalcin using 1H NMR spectroscopy.

Authors:  T L Dowd; J F Rosen; L Li; C M Gundberg
Journal:  Biochemistry       Date:  2003-07-01       Impact factor: 3.162

5.  C-terminal amidation of an osteocalcin-derived peptide promotes hydroxyapatite crystallization.

Authors:  Samaneh Hosseini; Hossein Naderi-Manesh; Driss Mountassif; Marta Cerruti; Hojatollah Vali; Shahab Faghihi
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

6.  Evidence for Osteocalcin Binding and Activation of GPRC6A in β-Cells.

Authors:  Min Pi; Karan Kapoor; Ruisong Ye; Satoru Kenneth Nishimoto; Jeremy C Smith; Jerome Baudry; Leigh Darryl Quarles
Journal:  Endocrinology       Date:  2016-03-23       Impact factor: 4.736

7.  The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors.

Authors:  Hongjie Yuan; Katie M Vance; Candice E Junge; Matthew T Geballe; James P Snyder; John R Hepler; Manuel Yepes; Chian-Ming Low; Stephen F Traynelis
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

8.  The half-life of the bone-derived hormone osteocalcin is regulated through O-glycosylation in mice, but not in humans.

Authors:  Omar Al Rifai; Catherine Julien; Julie Lacombe; Denis Faubert; Erandi Lira-Navarrete; Yoshiki Narimatsu; Henrik Clausen; Mathieu Ferron
Journal:  Elife       Date:  2020-12-07       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.